Homestead Advisers Corp Nuvasive Inc Transaction History

Homestead Advisers Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$36.81 - $48.12 $548,469 - $716,988	-14,900 Reduced 14.44%	88,300 $3.65 Million
Q3 2022 Nov 07, 2022	BUY	$42.51 - $54.02 $569,634 - $723,868	13,400 Added 14.92%	103,200 $4.52 Million
Q2 2022 Aug 01, 2022	BUY	$46.84 - $59.75 $1.23 Million - $1.57 Million	26,300 Added 41.42%	89,800 $4.42 Million
Q3 2021 Nov 05, 2021	BUY	$56.91 - $67.81 $381,297 - $454,327	6,700 Added 11.8%	63,500 $3.8 Million
Q4 2020 Feb 10, 2021	BUY	$43.41 - $56.51 $2.47 Million - $3.21 Million	56,800 New	56,800 $3.2 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

Stay updated on Homestead Advisers Corp with notifications on news.